Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

Patricia McGill is among the oldest people in the U.S. with sickle cell disease, and she attributes her longevity to optimism ...

Editorial writers explain these public health issues.